The bill enacted as R.S. 40:978.2.2 establishes new requirements for hospitals regarding drug screening for minors treated for suspected opioid overdoses. Specifically, it mandates that if a minor undergoes a urine drug screening, the hospital must include testing for fentanyl. This measure aims to enhance the diagnosis and treatment of opioid-related conditions in minors.

Additionally, if fentanyl is detected in the urine drug screening, the hospital is required to report the de-identified test results to the Louisiana Department of Health, office of public health. The bill also stipulates that hospitals must adhere to any mandatory reporting requirements outlined in the Children's Code Articles 609 and 610, ensuring comprehensive compliance with state regulations regarding the health and safety of minors.